UDC:615.825.:613.25–055.2
The aim of the work is to highlight the modern methods of obesity treatment that are used in medicine in different countries. Obesity is a health problem in most developed countries. Concomitant diseases may include disorders of lipid metabolism with increased atherogenic LDL levels, coronary artery disease, hypertension, type 2 diabetes, various diseases of the gastrointestinal tract, etc. Currently, medications along with diet and exercises are used in the treatment of obesity. Centrally acting drugs that reduce food intake by reducing appetite, as well as drugs that reduce the absorption of food components (example: orlistat) are prescribed. Hormonal regulation of accumulation or consumption of fat in depots is quite complicated and has not yet been fully studied. Much attention is paid to the study of the pathogenesis of obesity, in particular the effects of adipose tissue hormones, such as leptin, ghrelin. Leptin is considered a hormone that increases with obesity and signals the brain about the presence of sufficient fat reserves in the body. We have investigated the level of leptin in somatically healthy young people with obesity. Statistical analysis showed that the blood leptin level in the obese group was 42.8 (35.42; 45.06) ng/ml. The normal level of leptin in the blood is up to 5.6 ng/ml.